These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 32643269
1. Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function. Gohda T, Kamei N, Kubota M, Tanaka K, Yamashita Y, Sakuma H, Kishida C, Adachi E, Koshida T, Murakoshi M, Hagiwara S, Funabiki K, Ueda S, Suzuki Y. J Diabetes Investig; 2021 Mar; 12(3):382-389. PubMed ID: 32643269 [Abstract] [Full Text] [Related]
3. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy. Sonoda Y, Gohda T, Suzuki Y, Omote K, Ishizaka M, Matsuoka J, Tomino Y. PLoS One; 2015 Mar; 10(4):e0122212. PubMed ID: 25860248 [Abstract] [Full Text] [Related]
6. Circulating TNF receptor levels are associated with estimated glomerular filtration rate even in healthy individuals with normal kidney function. Gohda T, Murakoshi M, Shibata T, Suzuki Y, Takemura H, Tsuchiya K, Okada T, Wakita M, Horiuchi Y, Tabe Y, Kamei N. Sci Rep; 2024 Mar 27; 14(1):7245. PubMed ID: 38538662 [Abstract] [Full Text] [Related]
9. Assessment of serum concentration and urinary excretion of tumor necrosis factor receptor 1 and 2 and their potential as markers of immunoglobulin A nephropathy activity. Miedziaszczyk M, Oko A, Wolc A, Woźniak A, Idasiak-Piechocka I. Adv Clin Exp Med; 2024 Jun 27; 33(6):583-591. PubMed ID: 37962255 [Abstract] [Full Text] [Related]
14. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Niewczas MA, Ficociello LH, Johnson AC, Walker W, Rosolowsky ET, Roshan B, Warram JH, Krolewski AS. Clin J Am Soc Nephrol; 2009 Jan 27; 4(1):62-70. PubMed ID: 19073786 [Abstract] [Full Text] [Related]
18. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study. Barr ELM, Barzi F, Hughes JT, Jerums G, Hoy WE, O'Dea K, Jones GRD, Lawton PD, Brown ADH, Thomas M, Ekinci EI, Sinha A, Cass A, MacIsaac RJ, Maple-Brown LJ. Diabetes Care; 2018 Apr 27; 41(4):739-747. PubMed ID: 29367427 [Abstract] [Full Text] [Related]
19. Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes. Doody A, Jackson S, Elliott JA, Canavan RJ, Godson C, Slattery D, Twomey PJ, McKenna MJ, le Roux CW, Docherty NG. J Diabetes Complications; 2018 Jan 27; 32(1):95-99. PubMed ID: 29122448 [Abstract] [Full Text] [Related]
20. Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis. Gohda T, Maruyama S, Kamei N, Yamaguchi S, Shibata T, Murakoshi M, Horikoshi S, Tomino Y, Ohsawa I, Gotoh H, Nojiri S, Suzuki Y. Sci Rep; 2017 Mar 03; 7():43520. PubMed ID: 28256549 [Abstract] [Full Text] [Related] Page: [Next] [New Search]